UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection

Journal of the American Heart Association, 2020-02, Vol.9 (3), p.e014873

2020

Volltextzugriff (PDF)

The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model

Neurobiology of disease, 2016-08, Vol.92 (Pt B), p.137-143

2016

Volltextzugriff (PDF)

Antiretroviral Therapy in Macrophages: Implication for HIV Eradication

Antiviral Chemistry and Chemotherapy, 2009-10, Vol.20 (2), p.63-78

2009

Volltextzugriff (PDF)

Targeting Macrophage Dysregulation for Viral Infections: Novel Targets for Immunomodulators

Frontiers in immunology, 2021-11, Vol.12, p.768695-768695

2021

Volltextzugriff (PDF)

Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro

Journal of neuroinflammation, 2019-09, Vol.16 (1), p.182-182, Article 182

2019

Volltextzugriff (PDF)

The identification of intact HIV proviral DNA from human cerebrospinal fluid

Neurotherapeutics, 2024-07, Vol.21 (4), p.e00373, Article e00373

2024

Volltextzugriff (PDF)

Cognitively Based Compassion Training for HIV Immune Nonresponders-An Attention-Placebo Randomized Controlled Trial

Journal of acquired immune deficiency syndromes (1999), 2022-03, Vol.89 (3), p.340-348

2022

Volltextzugriff (PDF)

Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors

PLoS pathogens, 2017-12, Vol.13 (12), p.e1006740-e1006740

2017

Volltextzugriff (PDF)

Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections

Frontiers in immunology, 2022-12, Vol.13, p.1033672-1033672

2022

Volltextzugriff (PDF)

Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV

Frontiers in immunology, 2019-10, Vol.10, p.2267-2267

2019

Volltextzugriff (PDF)

Readily available drugs and other interventions to potentially improve the efficacy of immune checkpoint blockade in cancer

Frontiers in immunology, 2024-01, Vol.14, p.1281744

2024

Volltextzugriff (PDF)

The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency

Frontiers in immunology, 2021-08, Vol.12, p.720697-720697

2021

Volltextzugriff (PDF)

Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages

The Journal of biological chemistry, 2010-12, Vol.285 (50), p.39380-39391

2010

Volltextzugriff (PDF)

The role of the HIV-1 gut reservoir in driving early cardiovascular events in people living with HIV

Frontiers in drug discovery, 2024-10, Vol.4

2024

Volltextzugriff (PDF)

The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment

Frontiers in cellular neuroscience, 2023-04, Vol.17, p.1130938

2023

Volltextzugriff (PDF)

Host SAMHD1 protein restricts endogenous reverse transcription of HIV-1 in nondividing macrophages

Retrovirology, 2018-10, Vol.15 (1), p.69-69, Article 69

2018

Volltextzugriff (PDF)

Synthesis and antiviral evaluation of 2′,2′,3′,3′-tetrafluoro nucleoside analogs

Tetrahedron letters, 2017-02, Vol.58 (7), p.642-644

2017

Volltextzugriff (PDF)

Simultaneous Quantification of Intracellular Natural and Antiretroviral Nucleosides and Nucleotides by Liquid Chromatography−Tandem Mass Spectrometry

Analytical chemistry (Washington), 2010-03, Vol.82 (5), p.1982-1989

2010

Volltextzugriff (PDF)

A Rationale and Approach to the Development of Specific Treatments for HIV Associated Neurocognitive Impairment

Microorganisms (Basel), 2022-11, Vol.10 (11), p.2244

2022

Volltextzugriff (PDF)

Cellular Pharmacology and Potency of HIV-1 Nucleoside Analogs in Primary Human Macrophages

Antimicrobial Agents and Chemotherapy, 2013-03, Vol.57 (3), p.1262-1269

2013

Volltextzugriff (PDF)

Jak Inhibitors Modulate Production of Replication-Competent Zika Virus in Human Hofbauer, Trophoblasts, and Neuroblastoma cells

Pathogens & immunity, 2017-05, Vol.2 (2), p.199-218

2017

Volltextzugriff (PDF)

Treatment of HIV Associated Neurocognitive Disorder Mice with Curcumin Improves Cognitive Deficits (2359)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019

Clinical infectious diseases, 2021-04, Vol.72 (7), p.1247-1250

2021

Volltextzugriff (PDF)

Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus Reactivation In Vitro

Antimicrobial agents and chemotherapy, 2014-04, Vol.58 (4), p.1977-1986

2014

Volltextzugriff (PDF)

SAT441 - Novel cell culture 3D model for HBV/HIV co-infection and antiviral evaluation

Journal of hepatology, 2020-08, Vol.73, p.S871-S872

2020

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection

The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model

Antiretroviral Therapy in Macrophages: Implication for HIV Eradication

Targeting Macrophage Dysregulation for Viral Infections: Novel Targets for Immunomodulators

Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro

The identification of intact HIV proviral DNA from human cerebrospinal fluid

Cognitively Based Compassion Training for HIV Immune Nonresponders-An Attention-Placebo Randomized Controlled Trial

Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors

Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections

Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV

Readily available drugs and other interventions to potentially improve the efficacy of immune checkpoint blockade in cancer

The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency

Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages

The role of the HIV-1 gut reservoir in driving early cardiovascular events in people living with HIV

The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment

Host SAMHD1 protein restricts endogenous reverse transcription of HIV-1 in nondividing macrophages

Synthesis and antiviral evaluation of 2′,2′,3′,3′-tetrafluoro nucleoside analogs

Simultaneous Quantification of Intracellular Natural and Antiretroviral Nucleosides and Nucleotides by Liquid Chromatography−Tandem Mass Spectrometry

A Rationale and Approach to the Development of Specific Treatments for HIV Associated Neurocognitive Impairment

Cellular Pharmacology and Potency of HIV-1 Nucleoside Analogs in Primary Human Macrophages

Jak Inhibitors Modulate Production of Replication-Competent Zika Virus in Human Hofbauer, Trophoblasts, and Neuroblastoma cells

Treatment of HIV Associated Neurocognitive Disorder Mice with Curcumin Improves Cognitive Deficits (2359)

Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019

Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus Reactivation In Vitro

SAT441 - Novel cell culture 3D model for HBV/HIV co-infection and antiviral evaluation

Suchergebnisse filtern